Hyaluronan-phospholipid interactions

被引:96
作者
PasqualiRonchetti, I [1 ]
Quaglino, D [1 ]
Mori, G [1 ]
Bacchelli, B [1 ]
Ghosh, P [1 ]
机构
[1] UNIV SYDNEY,ROYAL N SHORE HOSP,RAYMOND PURVES BONE & JOINT RES LABS,ST LEONARDS,NSW 2065,AUSTRALIA
关键词
D O I
10.1006/jsbi.1997.3908
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyaluronan-phospholipid interactions have been studied in vitro by negative staining and rotary shadowing electron microscopy. Hyaluronan (HA) molecules of different molecular weights (around 170 000; 740 000, and 1.9 x 10(6) Ha) were added to phospholipid suspensions (DPPC or egg lecithin) that were in the form of either unilamellar particles or multilamellar vesicles. Suspensions were then gently stirred and incubated at different temperatures from 24 hr up to 7 days. After 24 hr, at temperatures just above the melting point of the phospholipid used, both unilamellar particles and multilamellar vesicles were already shown to change their organization in the presence of HA, giving rise to the formation of (1) huge perforated membrane-like structures lying on the substrate; (2) 12-nm-thick ''cylinders'' (rollers) with a tendency to aggregate and to form sheets. These structures were seen only in the presence of high-molecular-weight HA, whereas low-molecular-weight HA (170 kDa) induced fragmentation of liposomes and formation of a few short rollers. These data show,that phospholipids and HA interact and suggest they may also do so in vivo within the joint cavity, where both chemical species are present, giving rise to complexes which might exhibit peculiar lubricating and protective properties. It is also proposed that such interactions may not be as efficient in arthritic joints, where HA is degraded to low-molecular-weight fragments. (C) 1997 Academic Press.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 36 条
[1]   THICKNESS AND PRESSURE OF PLEURAL LIQUID IN SOME MAMMALS [J].
AGOSTONI, E ;
MISEROCC.G ;
BONANNI, MV .
RESPIRATION PHYSIOLOGY, 1969, 6 (02) :245-&
[2]   MECHANICS OF PLEURAL SPACE [J].
AGOSTONI, E .
PHYSIOLOGICAL REVIEWS, 1972, 52 (01) :57-&
[3]  
Balazs E., 1984, OSTEOARTHR CURR CLIN, V165, P174
[4]   HYALURONIC ACID IN SYNOVIAL FLUID .I. MOLECULAR PARAMETERS OF HYALURONIC ACID IN NORMAL AND ARTHRITIC HUMAN FLUIDS [J].
BALAZS, EA ;
WATSON, D ;
DUFF, IF ;
ROSEMAN, S .
ARTHRITIS AND RHEUMATISM, 1967, 10 (04) :357-&
[5]  
Balazs EA, 1974, DISORDERS KNEE, P61
[6]   SYNOVIAL FLUID LIPIDS IN NORMAL INDIVIDUALS AND PATIENTS WITH RHEUMATOID ARTHRITIS [J].
BOLE, GG .
ARTHRITIS AND RHEUMATISM, 1962, 5 (06) :589-&
[7]   CONCENTRATION AND MOLECULAR-WEIGHT OF SODIUM HYALURONATE IN SYNOVIAL-FLUID FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER ARTHROPATHIES [J].
DAHL, LB ;
DAHL, IMS ;
ENGSTROMLAURENT, A ;
GRANATH, K .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (12) :817-822
[8]   INTERACTIONS OF HYALURONAN (HYALURONIC-ACID) WITH PHOSPHOLIPIDS AS DETERMINED BY GEL-PERMEATION CHROMATOGRAPHY, MULTI-ANGLE LASER-LIGHT-SCATTERING PHOTOMETRY AND H-1-NMR SPECTROSCOPY [J].
GHOSH, P ;
HUTADILOK, N ;
ADAM, N ;
LENTINI, A .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1994, 16 (05) :237-244
[9]   RHEOLOGY OF HYALURONIC ACID [J].
GIBBS, DA ;
MERRILL, EW ;
SMITH, KA ;
BALAZS, EA .
BIOPOLYMERS, 1968, 6 (06) :777-&
[10]  
GOVONI E, 1990, 1 INT S SYN PHIL